QPT — Quest PharmaTech Cashflow Statement
0.000.00%
Last trade - 00:00- CA$5.92m
- CA$6.83m
- 32
- 83
- 12
- 38
Annual cashflow statement for Quest PharmaTech, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.68 | -13.3 | 190 | -85 | -7.33 |
| Depreciation | |||||
| Non-Cash Items | 2.42 | 1.11 | -186 | 84.7 | 6.99 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.659 | 5.75 | -6.61 | 0.082 | -0.225 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.91 | -6.38 | -2.52 | -0.171 | -0.555 |
| Capital Expenditures | -0.002 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 8.26 | 2.78 | 0.262 | -0.014 | -0.014 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 8.26 | 2.78 | 0.262 | -0.014 | -0.014 |
| Financing Cash Flow Items | -1.45 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.42 | 5.4 | 0.299 | 0.25 | 0.679 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.069 | 1.81 | -1.95 | 0.065 | 0.11 |